New Hampshire Amends Patient Privacy Law Following IMS v. Sorrell Decision
May 11, 2012 — In the wake of the June 2011 U.S. Supreme Court decision in IMS v. Sorrell, which ... read more
CMS: Sunshine Act Data Collection Will Be Delayed Until 2013
May 7, 2012 — The Centers for Medicare & Medicaid Services (CMS) stated on the CMS blog that following its ... read more
Guest Column: Heavy Meddle by Peter Pitts
May 7, 2012 — The American Recovery and Reinvestment Act (aka, “the stimulus package”) provided AHRQ with $29.5 million for ... read more
Proposed OTC Drug Distribution Would Expand Patient Access to “Rx” Drugs
April 30, 2012 – Comments are due May 7 on an FDA-proposed paradigm that would allow the agency to approve ... read more
PDUFA V Bills Moving Forward Without Specific Marketing Provisions
April 23, 2012 — The House and Senate both issued draft legislation last week to reauthorize the Prescription Drug User ... read more
CHC and TAC Comments Object to “Dual Modality” Risk Communication in DTC TV Ads
April 16, 2012 – The Coalition for Healthcare Communication (CHC) and The Advertising Coalition (TAC) recently told the FDA’s Office ... read more
ACRE Study Finds Medical Journal Discussion of Academic/Industry Relationships Unbalanced
April 12, 2012 – The Association of Clinical Researchers and Educators (ACRE) announced yesterday the publication of a study in ... read more
FDA Draft Guidance on DTC TV Ads Raises Important Questions
By John Kamp April 9, 2012 – The only thing really clear about the new guidance on pre-review of the ... read more
FTC to Industry: Adopt Consumer Privacy Best Practices Now
March 28, 2012 – Industry members needing another reason to join the fray of companies participating in the Digital Advertising ... read more
Call for Industry Comments: Proposed FDA Study on “Corrective” DTC TV Advertising
March 26, 2012 – Note to Industry Leaders The Coalition for Healthcare Communication needs your input on a study FDA ... read more
New Video Highlights Advances in CME Conflicts of Interest Policies
March 19, 2012 – A new video produced by CME Peer Review – “Conflict of Interest: The Bottom Line” – ... read more
FDA Draft Guidance on DTC TV Ads Identifies Campaigns Subject to 45-day Pre-Review Process
March 13, 2012 – Draft guidance released today by the FDA – “Guidance for Industry Direct-to-Consumer Television Advertisements” – calls ... read more
DAA’s Self-regulatory Ad Program to Protect Consumers Online Is Praised by White House, DOC and FTC
Feb. 23, 2012 – At a White House meeting held today to unveil the blueprint for the Obama Administration’s “Consumer ... read more
Coalition Calls for Substantial Revisions to Sunshine Act Proposed Rules
Feb. 16, 2012 – Further notice and comment are necessary for the implementation of Section 6002 of the Affordable Care ... read more
Digital Health Coalition Issues Guiding Principles and Best Practices to Help Lead Way on Robust Use of Social Media by Medicine Companies
Feb. 7, 2012 – Responding to patient and professional calls for more industry participation in the Internet and social media, ... read more
Digital Advertising Alliance Launches Consumer Education Campaign
Jan. 27, 2012 – The Digital Advertising Alliance (DAA) last week launched its “Your AdChoices” public education campaign to inform ... read more
MMM: CME Video Addresses Conflict of Interest
Jan. 26, 2012 – Avoiding conflict of interest in continuing medical education (CME) may seem like a daunting task, but ... read more
Does Novo Nordisk’s Victoza + Paula Deen = Recipe for Success?
Jan. 20, 2012 – Common sense should tell people that some of celebrity chef Paula Deen’s infamously unhealthy dishes – ... read more
Sunshine or Rain?
By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Jan. 17, 2012 – The Affordable Care Act ... read more
MMM Features Kamp’s Call for Industry Leadership on Off-label, Online Communications
Jan. 6, 2012 — This article, written by Coalition for Healthcare Communication Executive Director John Kamp, was featured in the ... read more
FDA Issues Draft Guidance on Unsolicited Off-label Info Requests, Addresses both Professional and Internet Media
Jan. 2, 2012 – In the waning days of 2011, the FDA released a significant draft guidance on company responses to ... read more
FDA Approval Report Contains Good News for Patients and Industry
By John Kamp, Executive Director, Coalition for Healthcare Communication – Nov. 7, 2011 – Until the research labs and ... read more
RPM Report: Pandora’s Box Officially Open as New Legal Challenges to FDA’s Off-label Restrictions Emerge
Oct. 24, 2011 – After the U.S. Supreme Court struck down speaker- and content-based restrictions in Sorrell v. IMS Health, ... read more
Par Pharma Case Asserts That First Amendment Protects Truthful Off-label Speech
Oct. 18, 2011 – A case filed by Par Pharmaceutical, Inc. against the FDA seeks to preserve Par’s First Amendment ... read more
Kamp on the Sunshine Act: Collaboration Key to Patient Care
Dec. 14, 2011 — UPDATE — CMS has published the proposed rules enforcing the Sunshine provisions of the Affordable Care ... read more
Experts Weigh In on Implications of Sorrell Decision
Aug. 1, 2011 — The recent Supreme Court decision in Sorrell v. IMS Health Inc. is earning robust commentary in ... read more
Academic Detailing and Health Plan Communications: Is the Playing Field Level?
By Kenneth P. Berkowitz, Esq. July 21, 2011 — Why does the government fail to apply current regulatory requirements and ... read more
Sorrell v. IMS: What Marketing Professionals Need to Know
By John Kamp, Executive Director, Coalition for Healthcare Communication July 18, 2011 — For those who have not read the ... read more
Kamp Column: Industry Must Embrace Internet and Social Media or Become Irrelevant in Many Health Conversations
By John Kamp, Executive Director, Coalition for Healthcare Communication June 29, 2011 — Yesterday I had the pleasure of moderating ... read more
PhRMA Survey Shows That Physicians Value Industry Communication
March 31, 2011 — At a time when interaction between biopharmaceutical companies and physicians is under increased scrutiny, a recent ... read more
del.icio.us
Digg
Facebook
LinkedIn
Twitter
Yahoo! BuzzPartners
© 2010 Coalition for Healthcare Communication. All rights reserved.
Powered by WordPress
Recent Comments